Mpox Resurfaces in Madagascar, Raising Regional Health Alert
Table of Contents
A limited outbreak of Mpox, formerly known as monkeypox, has been confirmed in Madagascar, prompting heightened surveillance across the indian Ocean region.
Madagascar is currently grappling with a localized outbreak of Mpox,with five confirmed cases identified in the coastal town of Mahajanga as of December 31.Health authorities are closely monitoring eleven additional suspected cases, aiming to contain the spread amidst increased travel during the holiday season. While the situation is presently contained, the emergence of the virus has triggered a regional alert, notably for neighboring countries and the French departments of Mayotte and Reunion.
Initial Outbreak and Response in Madagascar
the first confirmed cases of Mpox in Mahajanga were identified through analysis conducted by the Pasteur Institute of Madagascar. The infections were concentrated in a district along the Mahajanga seafront, according to reports from the Malagasy Medical Analysis Laboratory.Four patients requiring hospitalization experienced a deterioration in their condition,but “significantly improved” according to official statements. Remaining individuals with suspected or confirmed cases have been placed in isolation to prevent further transmission.
Mpox spreads through close contact with an infected person,including transmission via saliva,sneezing,and sexual contact. Common symptoms include fever, headache, and a characteristic rash. The Malagasy government is prioritizing containment efforts in Mahajanga, recognizing the increased risk posed by gatherings and tourism-related travel.
To mitigate the spread, authorities have reinforced preventative measures, including mandatory mask-wearing, frequent handwashing, health screenings at the port and Mahajanga airport, and public awareness campaigns promoting barrier gestures.
Regional Vigilance: Mayotte and Reunion on Alert
The resurgence of Mpox in Madagascar is being closely watched by the French departments of Mayotte and Reunion, which share important regional mobility patterns with the island nation. These dynamics facilitate the circulation of viruses, making proactive surveillance crucial.
Mayotte has not recorded any new cases of Mpox since 2022, with the two confirmed cases that year being classified as imported and presenting with mild symptoms.The island’s surveillance system relies on robust contact tracing, isolation protocols, and targeted vaccination efforts.
Reunion experienced several sporadic cases of Mpox between 2022 and June 2024. Their strategy centers on rapid case identification, vaccination for at-risk populations, and continuous epidemiological surveillance.
Currently, authorities in both Mayotte and reunion are leveraging past experiences to prioritize prevention. Self-monitoring,rapid reporting of symptoms,isolation of confirmed cases,and targeted vaccination remain the cornerstones of their health response. As one official stated, this approach is “nothing spectacular, but a well-established, sometimes thankless mechanism” essential for navigating a regional context where geographical boundaries do little to impede viral spread.
Why did the outbreak occur? The outbreak in Madagascar is localized to the coastal town of Mahajanga, with the first cases identified in December 2023. The exact source of the outbreak is currently unknown, but the increased travel during the holiday season is considered a contributing factor.
Who is affected? As of December 31, five cases have been confirmed in Madagascar, with eleven additional suspected cases under investigation. Four hospitalized patients experienced a deterioration in condition but have since improved. The French departments of May
